west china medical publishers
Keyword
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Keyword "肝脏肿瘤" 15 results
  • 内镜结扎在治疗静脉曲张出血中的作用

    Release date:2016-08-28 05:30 Export PDF Favorites Scan
  • 大鼠肝种植性肿瘤SMCR86模型制作

    Release date:2016-08-29 09:20 Export PDF Favorites Scan
  • Clinical Application of Laparoscopic Hepatectomy

    Objective To approach the indications, techniques features, and efficacy of laparoscopic hepatectomy for liver tumor. Methods The clinical data and follow-up results of 61 patients who received laparoscopic hepatectomy at our institute from January, 2007 to December, 2012 were retrospectively analyzed. Results Of the 61 patients, 16 cases were with primary liver cancer, 1 case with liver adenocarcinoma, 2 cases with metastatic liver cancer, 31 cases with hepatic hemangioma, and 11 cases with other benign liver diseases (including hepatocellular adenoma, focal nodular hyperplasia, hepatic cysts, and mucinous cystadenoma). The average tumor diameter was 5.6 cm (2-15 cm). The surgical approaches includes laparoscopic hepatic left lateral lobectomy (42 cases), right posterior lobectomy (2 cases), hepatectomy of segmentⅥ (3 cases), hepatectomy of segmentsⅦ/Ⅷ, Ⅳa, and caudate lobe (one respectively). Non-anntomic and wedge resection were performed on 11 patients. The mean operating time, blood loss, postoperative hospital stay, and postoperative complication rate were (124±65) min (50-200min), (251±145) mL (50-1 000mL),(7.3±3.6) d (4-11d), and 16.3% (10/61), respectively. In 19 cases with malignant liver lesions, 15 cases were followed up mean for 26 months (1-48 months). One of them died in 1 year after operation for multiple organ dysfunction, others were survival. Conclusions Experienced laparoscopic surgery doctors selected appropriate cases, used proper blood inflow oclussion and liver resction methods, and cared for tumor-free principle, the laparoscopic hepatectomy for malignant and benign tumors of liver could be safe and effective to carry out.

    Release date:2016-09-08 10:25 Export PDF Favorites Scan
  • Clinical Evaluation of Laparoscopic Liver Resection for Liver Tumor

    Objective To approach the clinical effect,feasibility, and advantages and disadvantages of laparoscopic liver resection for liver tumor. Methods The clinical data of 32 patients with liver tumor underwent laparoscopic liver resection from January 2009 to August 2011 in this hospital were analyzed retrospectively. Results The laparoscopic liver resection of 32 patients with liver tumor were performed successfully,including 23 cases of primary liver cancer,5 cases of metastatic liver,3 cases of liver hemangioma,1 case of focal liver nodular hyperplasia. Laparoscopic liver resection included left lateral lobectomy (Ⅱ+Ⅲ segments) in 17 cases,left internal lobectomy (Ⅳ segment) in 2 cases (left lateral lobe was already removed),left hemihepatectomy (Ⅱ+Ⅲ+Ⅳ segments) in 8 cases,Ⅴsegmentectomy in 1 case,and Ⅵ segmentectomy in 1 case,and Ⅲ,Ⅳ,and Ⅴ segments hemihepatectomy in 3 cases. The average operation time of hepatectomy was 75-285 min with an average 215 min. Intraoperative bleeding was 115-760 ml with an average 365 ml. No complications such as bile leakage,hemorrhage,air embolism, and so on happened. The time of gastrointestinal function recovery was 1-3 d. The hospital stay was 5-11 d with an average 6 d. Thirty-one cases were followed-up,the follow-up time was 6-32 months with an average 18 months,except one case was died of tumor recurrence and metastasis in one year after operation,the rest were alive,no tumor recurrence and metastasis happened. Conclusions Laparoscopic liver resection for liver tumor has a small wound,less suffering,quick recovery,which is safe and feasible. The clinical effect is good.

    Release date:2016-09-08 10:37 Export PDF Favorites Scan
  • Effect of Silencing of Hypoxia Inducible Factor-1 Alpha Gene on Chemosensitivity of Human Hepatocellular Carcinoma Cells and Correlative Mechanisms

    【 Abstract 】 Objective To observe the effect of disruption of hypoxia inducible factor-1 α (HIF-1 α ) pathway by small hairpin RNA (shRNA) on chemosensitivity of human hepatocellular carcinoma (HCC) cells and to reveal the correlative mechanisms. Methods Plasmid of pshRNA-HIF-1α was transfected into HepG2 cells by lipofectamine. HepG2/pshRNA-HIF-1α (HepG2/pshRNA) cell lines were obtained by selection of HepG2 cells in G418. Meanwhile, plasmid of empty vector (pHK) was transfected as a control (HepG2/pHK). The mRNA and protein expression levels of HIF-1α and mdr1 were investigated by RT-PCR and Western blot respectively. Using CoCl2 to simulate the hypoxia condition, growth inhibition and apoptosis rates of HepG2 cells under different dosages of chemotherapeutic agents (adriamycin) were measured by MTT assay and flow cytometry (FCM) . ResultsCompared with HepG2/pHK cells, the mRNA and protein expression levels of HIF-1αand mdr1 were obviously down-regulated in HepG2/pshRNA cells. At the same time, the proliferation inhibition and apoptosis rates were evidently increased after transfection with pshRNA-HIF-1α(P<0.05),which decreased the expression of HIF-1αto 82.18% at mRNA level and 75.51% at protein level. There was no significant effect of transfection pHK (Pgt;0.05). Conclusion These data demonstrates that HIF-1α interference by shRNA increased the sensitivity of HCC chemotherapy and the reversal of multidrug resistance, which may be done by down-regulating the transcription of mdr1 and the translation of P-gp. Blocking HIF-1αin HCC cells may offer an new avenue for gene therapy.

    Release date:2016-09-08 11:45 Export PDF Favorites Scan
  • Multi-Detector-Row Helical CT Features of Hepatic Metastases from Adenocarcinoma of Digestive Tract

    【Abstract】Objective To investigate the CT imaging features of metastatic hepatic adenocarcinomas from the digestive tract by using multidetectorrow helical CT (MDCT) with pathological correlation. Methods CT and clinical data of 36 patients with pathologically proven metastatic hepatic adenocarcinomas from the digestive tract were retrospectively reviewed. The primary tumors included 10 cases of gastric cancer, 1 duodenal cancer, 18 colonic carcinoma, 7 rectal cancer. All patients underwent MDCT plain scan and contrastenhanced dualphase scanning of upper or whole abdomen. The appearances of hepatic metastatic lesions on MDCT images at various enhancement phases were carefully observed. Results On plain CT scan 32 cases (88.9%) presented multiple nodules of low density at different sizes, 3 cases (8.3%) showed a single low-density nodule, and 1 case presented with a cystic mass. On contrast-enhanced scan, 4 cases (11.1%) showed faintly enhanced rim around the nodules on arterial phase; on portal venous phase 29 cases (80.6%) presented slight ringlike enhancement at the periphery of the nodule while the nodule core was markedly hypodense with intermediate soft tissue density area in between, giving rise to the typical appearance of “bull’seye” sign. Three cases (8.3%) showed no enhancement on either phase images. Conclusion The ring-like enhancement and the appearance of “bull’s-eye” on portal venous phase was characteristic CT features of metastatic hepatic adenocarcinoma from digestive tract.

    Release date:2016-09-08 11:54 Export PDF Favorites Scan
  • Clinical Summary of da Vinci Surgery System in Liver Tumor Resection

    ObjectiveTo discuss the feasibility, safety, and superiority of da Vinci surgery system (DVSS) in liver tumor resection. MethodThe clinical data of 21 patients who underwent DVSS in the liver tumor resection were analyzed retrospectively. ResultsThere were 12 patients with hepatocellular carcinoma (HCC), 1 patient with cholang-iocellular carcinoma, 1 patient with hepatic cirrhosis regenerative nodule, 2 patients with metastatic adenocarcinoma, 2 patients with leiomyosarcoma, and 3 patients with cavernous hemangioma.The operative time was (156.67±92.19) min (60-480 min), the intraoperative blood loss was (585.71±1 076.12) mL (50-5 000 mL), the time of diet recovery was (3.23±1.26) d (2-6 d), and the hospital stay was (10.10±9.02) d (5-47 d).The hospital mortality and morbidity rates were 0(0/21) and 9.52%(2/21) respectively including 1 patient with biliary leakage and 1 patient with abdominal infection. ConclusionThis study demonstrates the feasibility and safety of DVSS in the liver tumor resection and the system has a wide range of application for patients who are suffering from liver tumor.

    Release date: Export PDF Favorites Scan
  • Application of ultrasound-guided percutaneous co-axial technique in liver tumor biopsy of 150 patients from 2015 to 2016

    ObjectiveTo evaluate the clinical value of ultrasound-guided percutaneous co-axial technique in liver tumor biopsy.MethodsThe clinical data of patients who received ultrasound-guided percutaneous co-axial liver tumor biopsy from March 2015 to December 2016 in West China Hospital of Sichuan University were collected to retrospectively analyze the outcomes of biopsy success rate, sampling number, pathology diagnostic rate and incidence of complications.ResultsA total of 150 patients involving 99 males and 51 females were included, with a mean age of 54.9±4.5 years. The mean tumor size was 2.4±1.2cm. The ultrasound-guided liver tumors biopsy success rate was 100% (150/150). The mean sampling frequency was 2.4±0.6 times. Complications after biopsy included mild local pain (37%, 56/150) and bleeding (0.7%, 1/150).ConclusionUltrasound-guided co-axial biopsy is an simple, safe and efficient image-guided biopsy technique which allows multiple sample acquisition and reduces complications.

    Release date:2018-06-04 08:48 Export PDF Favorites Scan
  • The clinical application and progress of indocyanine green-fluorescence imaging in liver tumor surgery

    Objective To summarize the application and progress of the indocyanine green-fluorescence imaging in liver tumor surgery, at the same time, to demonstrate the advantages, limitations, and prospects of this technology. Methods Clinical researches about indocyanine green-fluorescence imaging in liver tumor surgery were collected, to review the introduction and principle of indocyanine green-fluorescence imaginging, and its clinical application of detecting small lesions and demarcating boundaries in liver tumor surgery. Results Indocyanine green-fluorescence imaging had been used in liver tumors surgery. In the aspect of locating the tumors, detecting small lesions, and demarcating boundaries, it had begun to show its unique value. And it was provided to be a new way to reduce tumor recurrence, improve treatment effect, and prolong survival time. Conclusions Indocyanine green-fluorescence imaging is now in the stage of development and promotion, and it has great development potential in technology. But, it also needs advancement in identification ability of benign and malignant lesions, and the depth of detection.

    Release date:2018-08-15 01:54 Export PDF Favorites Scan
  • Hepatic epithelioid angiomyolipoma: report of 5 cases

    ObjectiveTo summarize clinicopathologic and immunophenotypic features of hepatic epithelioid angiomyolipoma (HEAML) and to explore its diagnostic and differential diagnostic methods.MethodThe clinical and imaging manifestations, pathological morphology and immunohistochemical features of 5 patients with HEAML from August 2011 to December 2017 in this hospital were retrospectively analyzed.ResultsThere were 2 males and 3 females in the 5 patients with HEAML, aged 38–64 years with an average age of 50 years. There were 2 cases of the left lobe tumors and 3 cases of the right lobe tumors. Three cases were diagnosed as the hepatocellular carcinoma and the other two cases were diagnosed as the hepatic hamartoma and (or) hemangioma by the preoperative imaging examination. The diameter of tumors ranged from 1.5 cm to 7.0 cm, with an average of 3.6 cm. Microscopically, the tumors were composed of more epithelioid smooth muscle cells, parenchyma vessels and a small amount of fat. The immunohistochemical results showed that the melan-A, HMB45, and SMA were positive, while the HepPar-1, AE1/AE3, EMA, CD117, Dog-1, CD10, CgA, Syn, and Desmin were negative. The Ki-67 proliferation index was 2%–10%. The patients were all alive without the tumor recurrence after following up for 2–76 months with an average of 31.4 months.ConclusionsHEAML is a rare primary mesenchymal tumor of liver, which should be misdiagnosed for other benign or malignant tumors for influencing clinical treatment. Diagnosis and differential diagnosis can be made by histopathology and immunohistochemical staining.

    Release date:2019-06-05 04:24 Export PDF Favorites Scan
2 pages Previous 1 2 Next

Format

Content